Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05659394 · ClinicalTrials.gov registry record · NA
Intermittent Pneumatic Compression of the Thigh
A NA study of Venous Leg Ulcer, sponsored by Huntleigh Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 5
- Study locations
NCT05659394 is a NA study of Venous Leg Ulcer that has completed, run by Huntleigh Healthcare. The registered enrollment target is 136 participants, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (44% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT05659394, a NA study of Venous Leg Ulcer, has completed, sponsored by Huntleigh Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 5
- Study locations
Study Summary
Study Summary A leg ulcer is a long-lasting (chronic) sore that takes more than two weeks to heal. The majority of leg ulcers are caused either by problems with the veins in the legs; these are called 'venous leg ulcers' (VLU), or a combination of both venous and arterial disease which affects the veins and arteries in the leg; these are called 'mixed aetiology ulcers'(MLU). Venous and mixed aetiology leg ulcers are usually treated by applying a simple non-stick dressing to the ulcer with a firm compression bandage applied on top. These bandages are designed to squeeze the legs and encourage blood flow towards the heart. Before this treatment starts, a patient may undergo tests to check the flow of blood in the leg arteries is adequate. This ensures that compression bandaging can be safely applied to assist wound healing without compromising arterial blood flow. Most venous and mixed aetiology leg ulcers heal within three to four months if they're treated by a healthcare professional trained in compression therapy for leg ulcers. However, some ulcers can be more problematic and may persist for many months or even years despite being treated with the gold standard treatment of compression bandages. We therefore need to find more ways of helping these problematic ulcers to heal. Intermittent Pneumatic Compression (or IPC) is another way of compressing legs to try and improve the circulation. IPC consists of a sleeve or garment which is applied to the leg. The sleeve is connected to a pump which gently inflates and then deflates it to squeeze the leg in a massage like manner. The IPCOTT study aims to find out if a new IPC device, known as the WoundExpress can help to heal leg ulcers. The WoundExpress has a sleeve that patients put around the thigh, like the one applied to the arm when people have their blood pressure taken. Users need to be either sitting with their legs raised or lying down when using the device. Pressing the 'start' button on the pump causes the
Conditions Studied
Interventions
- OTHER Standard Wound Care Alone
- DEVICE Stand Wound Care plus IPC
Study Locations (5)
Florida
- Royal Research - Hollywood
- Three Rivers Wound and Hyperberic - North Port
Oklahoma
- Wound Care of Tulsa - Tulsa
Pennsylvania
- SerenaGroup - Monroeville
Texas
- SerenaGroup Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05659394
The ClinicalTrials.gov registry entry for NCT05659394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (44% lower). The listed sponsor is Huntleigh Healthcare, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard Wound Care Alone is the first listed.
NCT05659394 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, Oklahoma, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05659394 about?
NCT05659394 is a clinical study titled "Intermittent Pneumatic Compression of the Thigh". Study Summary A leg ulcer is a long-lasting (chronic) sore that takes more than two weeks to heal. The majority of leg ulcers are caused either by problems with the veins in the legs; these are called 'venous leg ulcers' (VLU), or a combination of both venous and arterial disease which affects the ...
What is the current status of trial NCT05659394?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2023-01-25. Estimated completion is 2024-03-31.
What conditions does trial NCT05659394 study?
This clinical trial studies the following conditions: Venous Leg Ulcer.
What interventions are being tested in trial NCT05659394?
The interventions under investigation include: Standard Wound Care Alone (OTHER), Stand Wound Care plus IPC (DEVICE).
Who is sponsoring clinical trial NCT05659394?
This trial is sponsored by Huntleigh Healthcare, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05659394 being conducted?
This trial has 5 study locations across Florida, Oklahoma, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.